Biomarkers tested Fasting lipid panel LDL Homocysteine HDL Total cholesterol Triglycerides hs-CRP Apolipoprotein B (ApoB) Lipoprotein(a) Glucose & insulin Homocysteine level Treatments offered Long term benefits Lower heart attack risk Slowed progression of atherosclerosis Improved blood pressure Lower heart attack risk Healthier cholesterol levels Enhanced exercise capacity and energy Increased longevity and quality of life We detect imbalances like insulin resistance long before diabetes develops
How should doctors counsel their patients about peptides that have not been FDA approved
0.25 mg once daily for 3 to 4 weeks 0.25 to 0.5 mg once daily for 4 to 6 weeks 0.5 mg split into two daily doses for 6 to 8 weeks Subcutaneous, 1 to 2 inches from injury location Conservative vs
Why isnt it approved yet
Tween 60 or 80), talcum, starch, lactose and tragacanth, magnesium stearate, glycerol, propylen glycol, preserving agents, benzyl alcohol, methylhydroxy benzoate and/or oleum arachid hydrogen
Fear of needles, concerns about sterile technique, discomfort, and the psychological barrier of self-injection all limit adoption of injectable peptides
